Michihiro Takahashi

发表

Long‐term safety and tolerability of atomoxetine in Japanese adults with attention deficit hyperactivity disorder

P. Trzepacz, A. Allen, Yuko Hirata, 2014, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

Chronic dexamethasone administration decreases noradrenaline-stimulated, but not serotonin-stimulated, phosphoinositide metabolism in the rat brain

S. Morinobu, M. Endoh, Michihiro Takahashi, 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention‐deficit hyperactivity disorder

T. Treuer, Dongwon Shin, G. Bahn, 2014, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

A successful clonazepam treatment without tolerance in a patient with spontaneous oral dyskinesia

K. Otani, Michihiro Takahashi, T. Fukasawa, 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation

H. Katagiri, J. Gómez, K. Fujita, 2013, BMC Psychiatry.

Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan

H. Ascher-Svanum, Michihiro Takahashi, W. Ye, 2012, ClinicoEconomics and outcomes research : CEOR.

Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan

H. Ascher-Svanum, Michihiro Takahashi, W. Ye, 2011, Patient preference and adherence.

Repeated stress increases catalytic TrkB mRNA in rat hippocampus

R. Duman, M. Nibuya, D. Russell, 1999, Neuroscience Letters.

A randomized, double-blind, placebo-controlled study of atomoxetine in Japanese children and adolescents with attention-deficit/hyperactivity disorder.

T. Koeda, A. Allen, K. Yamazaki, 2009, Journal of child and adolescent psychopharmacology.

Open‐label, dose‐titration tolerability study of atomoxetine hydrochloride in Korean, Chinese, and Taiwanese adults with attention‐deficit/hyperactivity disorder

S. Gau, Sang-Keun Chung, T. Goto, 2014, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

An open‐label, dose‐titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention‐deficit/hyperactivity disorder

H. Matsumoto, H. Ichikawa, T. Goto, 2011, Psychiatry and clinical neurosciences.

Efficacy and Safety of Atomoxetine Hydrochloride in Asian Adults With ADHD

P. Trzepacz, S. Gau, D. Song, 2017, Journal of attention disorders.

Stress Vulnerability Induced by Neonatal Isolation and the Disturbance Between the Phosphorylation and Dephosphorylation of CREB

S. Yamawaki, K. Fujimaki, S. Morinobu, 2006 .

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study

M. Tohen, S. Kanba, M. Case, 2013, BMC Psychiatry.

Schizophrenia Outpatient Health Outcomes study: twelve-month findings

J. Haro, H. Ascher-Svanum, Michihiro Takahashi, 2012, Pragmatic and observational research.

Remission, response, and relapse rates in patients with acute schizophrenia treated with olanzapine monotherapy or other atypical antipsychotic monotherapy: 12-month prospective observational study

M. Iyo, Michihiro Takahashi, S. Fujikoshi, 2015, Pragmatic and observational research.

Characteristics of Outpatients Initiated on Olanzapine versus Risperidone in the Treatment of Schizophrenia in Japan: A Healthcare Database Analysis

H. Ascher-Svanum, Michihiro Takahashi, W. Ye, 2011 .

Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study.

M. Tohen, S. Kanba, T. Higuchi, 2012, Journal of affective disorders.

Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder

M. Tohen, S. Kanba, T. Higuchi, 2012, Current medical research and opinion.

Solanezumab was safe and well-tolerated for Asian patients with mild-to-moderate Alzheimer's disease in a multicenter, randomized, open-label, multi-dose study

E. Siemers, R. Dean, S. Nishiuma, 2010, Alzheimer's & Dementia.

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis

R. Conley, H. Ascher-Svanum, Michihiro Takahashi, 2012, Neuropsychiatric disease and treatment.

Predictors of Discontinuation of Antipsychotic Therapy in Patients with Acute Schizophrenia: A 1-Year Observational Study with More Than 1000 Patients

M. Iyo, Michihiro Takahashi, J. Funai, 2014 .

One-year outcomes in schizophrenia after switching from typical antipsychotics to olanzapine in Japan: an observational study

H. Ascher-Svanum, T. Ohmori, Michihiro Takahashi, 2012, Pragmatic and observational research.

Clinical and functional outcomes for patients with schizophrenia treated with olanzapine: One-year naturalistic outcomes for inpatients and outpatients in Japan

H. Ascher-Svanum, Michihiro Takahashi, W. Ye, 2011 .

Improved outcomes following a switch to olanzapine treatment from risperidone treatment in a 1‐year naturalistic study of schizophrenia patients in Japan

H. Ascher-Svanum, T. Ohmori, Michihiro Takahashi, 2012, Psychiatry and clinical neurosciences.

Effect of Lithium on the Expression of Phosphodiesterase type 4B mRNA in the Rat Frontal Cortex and Hippocampus

K. Otani, Michihiro Takahashi, Muneaki Kanno, 2015 .

Safety and efficacy of olanzapine in the long‐term treatment of Japanese patients with bipolar I disorder, depression: An integrated analysis

M. Tohen, S. Kanba, M. Case, 2014, Psychiatry and clinical neurosciences.

Schizophrenia Outpatient Health Outcomes study: twelve-month findings

J. Haro, H. Ascher-Svanum, Michihiro Takahashi, 2012 .